Evidence map›Paper›PMID 41393019›Full record

Observational studyFrontiers in public health2025

The impact of COVID-19 management on the risk of exposure to specific chemical products: a multicentric Italian study based on 2017-2021 poison centers consultancies.

Felice Giordano, Lucrezia Lanciotti, Rosanna Maria Fidente, Leonello Attias, Valeria M Petrolini, Carlo A Locatelli, Giuseppe Bacis, Mariapina Gallo, Francesco Gambassi, Alessandra Ieri and 7 more

Abstract readMulticenter StudyObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Felice GiordanoNational Center for Chemicals, Cosmetics and Consumer Protection, Istituto Superiore di Sanità, Rome, Italy.
Lucrezia LanciottiNational Center for Chemicals, Cosmetics and Consumer Protection, Istituto Superiore di Sanità, Rome, Italy.
Rosanna Maria FidenteNational Center for Chemicals, Cosmetics and Consumer Protection, Istituto Superiore di Sanità, Rome, Italy.
Leonello AttiasNational Center for Chemicals, Cosmetics and Consumer Protection, Istituto Superiore di Sanità, Rome, Italy.
Valeria M PetroliniToxicology Unit, Pavia Poison Centre and National Toxicology Information Centre, Laboratories of Clinical and Experimental Toxicology, IRCCS Hospital of Pavia, Istituti Clinici Scientifici Maugeri, Pavia, Italy.
Carlo A LocatelliToxicology Unit, Pavia Poison Centre and National Toxicology Information Centre, Laboratories of Clinical and Experimental Toxicology, IRCCS Hospital of Pavia, Istituti Clinici Scientifici Maugeri, Pavia, Italy.
Giuseppe BacisBergamo Poison Control Center - ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.
Mariapina GalloBergamo Poison Control Center - ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.
Francesco GambassiMedical Toxicology Unit and Poison Control Centre, Careggi University Hospital, Florence, Italy.
Alessandra IeriMedical Toxicology Unit and Poison Control Centre, Careggi University Hospital, Florence, Italy.
Anna LeporePoison Centre of Puglia, Policlinico Riuniti di Foggia, Foggia, Italy.
Leonardo PennisiPoison Centre of Puglia, Policlinico Riuniti di Foggia, Foggia, Italy.
Francesco ColettaEmergency Anesthesia, Burn Intensive Care Unit and Poison Control Center, AORN Antonio Cardarelli, Naples, Italy.
Simone EspositoEmergency Anesthesia, Burn Intensive Care Unit and Poison Control Center, AORN Antonio Cardarelli, Naples, Italy.
Marco MaranoPediatric Poison Control Center, Children's Hospital Bambino Gesù, IRCCS, Rome, Italy.
Mara PisaniGeneral Pediatrics and Emergency Department 2nd Level, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Lucilla BaldassarriNational Center for Chemicals, Cosmetics and Consumer Protection, Istituto Superiore di Sanità, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: In Italy, the emergency of COVID-19 led to the promotion of preventive measures like hygiene protocols, biocides use, and lockdowns. This study assesses whether the Italian COVID-19 prevention Decrees led to significant changes in exposure to specific chemicals, also examining the post-COVID-19 period (2021). Materials and methods: This multicentric observational study analyzed 2017-2021 exposure data to specific chemicals coming from six Italian Poison Centres (PCs). A multivariate analysis valued the association between the exposure to a specific product category and the predictive variables in different periods of 2020 and 2021, calculating crude and adjusted ORs and applying the Bonferroni correction for multiple comparisons. Results: The issuing of Decrees against COVID-19 conducted to peaks in exposure to chemicals. Higher proportions of children aged 1-5 were found among patients exposed to Discussion: This study evaluated the risk of exposure to chemicals during 2020 and 2021 vs. 2017-2019, considering the association between periods and exposures to specific chemicals as a crucial factor to correctly conduct these kinds of epidemiological studies.

Indexed as

COVID-19Environmental ExposurePoison Control CentersAdolescentAdultChildChild, PreschoolDetergentsDisinfectantsFemaleHumansInfantItalyMaleMiddle AgedSARS-CoV-2DetergentsDisinfectantshazardous substancespoison control centerspoisoningpublic health surveillanceSARS-CoV-2 virus

Identifiers

PMID41393019
PMCPMC12695805

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.